A fugitive rapist from Rhode Island, who was captured last week after 21 years on the run, is expected to return to the state Friday.

Authorities took Ronald Fischer, 70, into custody last Thursday on a boat off New York.

Fischer has been held there since, but waived extradition.

Fischer disappeared in April 2005 while he was on trial in Newport.

Days later, a jury convicted him of raping a woman on his boat in Portsmouth.

The Manhattan District Attorney’s office told NBC 10 Thursday Fischer was due to be sent back to Rhode Island Friday.

Authorities in Rhode Island, however, have not corroborated the timing to NBC 10.

Fischer faces warrants in both state and federal court in Rhode Island for taking off.

He was not sentenced in the rape case following his disappearance.

Investigators are trying to piece together what Fischer was doing for the last 21 years on the run.

As NBC 10 reported Tuesday, investigators confirmed Fischer appears to have recently gotten work as a medical executive using a fake name.

Fischer appears to have been named to a board position with a California bio-pharmaceutical company earlier this year under the alias investigators say he’d been using for years as a fugitive, Dr. Richard Graydon.

U.S. Marshals in Rhode Island told NBC 10 Tuesday that under questioning after his capture Fischer maintained he was Graydon, but his fingerprints matched those of the Rhode Island rapist on the run.

He signed the extradition paperwork last Friday with the name Ronald Fischer.

Rhode Island U.S. Marshals told NBC 10 Tuesday they now believe Fischer was using the Graydon alias back until at least 2017 and was living in the New York area during that time.

They told NBC 10 they received a tip last week regarding Fischer’s identity that they developed over 48 hours.

While Fischer was known to have more than a dozen aliases before he disappeared in 2005, Richard Graydon was not one of them.

Investigators told NBC 10 Tuesday they found during their investigation last week there was no real person with that name with the medical credentials listed for him.

In March, a statement from Immix Biopharma said it brought on Dr. Graydon, “a board-certified hematologist-oncologist with over 20 years of experience in clinical development, most recently at Merck & Co. and Johnson & Johnson,” as its chief medical officer.

Immix notified federal regulators Monday that it fired Graydon Friday.

Johnson & Johnson told NBC10 it never employed such a person.

Merck has not responded.

Graydon’s name is also linked to other bio-pharma companies online.

One of them, Atossa Therapeutics, acknowledged to NBC 10 Graydon was an independent contractor for them for less than two weeks in 2022, but did not answer follow-up questions.

Another, Daiichi Sankyo wrote to NBC10, “Richard Graydon was not an employee of Daiichi Sankyo. A person by the name of Richard Graydon worked as a consultant through a third party for the company from 2016 to 2019. It is improper for Richard Graydon to list himself as an employee of Daiichi Sankyo on a CV, when authoring a publication or elsewhere.”

The U.S. Marshals investigators told NBC10 Fischer made up the Graydon persona and resume, but they’re not sure what positions he actually held prior to Immix.

Fischer was previously a different kind of doctor in Rhode Island, the head of anesthesiology at Memorial Hospital in Pawtucket and an assistant professor at Brown University.

However, his medical license was revoked in the 1990s after he was accused of raping a woman on a boat in Boston and eventually pleaded guilty to a lesser assault charge in that case.